Study guide

Pneumonia and infected pleural collections

AMC CAT MCQ Examination AMC Part 1

Track your progress as you read

Finished sections get a check mark.

1 Acute Coronary Syndromes & ECG Localization

ACS recognition and ECG localisation Reperfusion and infarction complications

2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias

Heart failure assessment and treatment Arrhythmias and conduction emergencies

3 Systemic Hypertension & Peripheral Vascular Disease

Blood pressure and cardiovascular risk Secondary hypertension and arterial disease

4 Valvular Heart Disease, Infective Endocarditis & Pericarditis

Aortic and mitral valve disease Endocarditis and pericardial emergencies

5 Asthma & COPD Acute Flares and Maintenance

Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations

6 Pneumonia, pleural disease and respiratory failure

Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis

7 GI bleeding, bowel inflammation and malabsorption

GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS

8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance

9 Diabetes, thyroid and adrenal disease

Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease

10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies

AKI and chronic kidney disease Potassium and sodium emergencies

11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment

Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care

12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis

Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia

13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology

Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms

14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis

Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment

15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries

Trauma primary survey and adjuncts Chest trauma and immediate threats

16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance

Head injury, imaging and haemorrhage Herniation and spinal cord injury

17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome

Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury

18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care

Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus

19 Aortic Aneurysms & Acute Arterial Limb Ischaemia

Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia

20 Urological Emergencies, Testicular Torsion & Haematuria Investigation

Retention, stones and obstructed infection Scrotal pain and haematuria

21 Preoperative Risk Stratification & Postoperative Surgical Complications

Preoperative assessment and medicines Postoperative complications and prevention

22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening

Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons

23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy

Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding

24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies

Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth

25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care

26 Contraception, Emergency Contraception & Pregnancy Termination

Contraceptive choice and missed pills Emergency contraception and abortion

27 Australian Cervical Screening Program & Gynaecological Malignancies

Cervical screening and cervical cancer Endometrial and ovarian cancer

28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice

Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening

29 Developmental Milestones, Growth Charts & Failure to Thrive

Developmental milestones Regression, autism and support Faltering growth and developmental comparisons

30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions

Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons

31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis

Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis

32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease

Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up

33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury

Pyloric stenosis Intussusception and dehydration Child protection and injury assessment

34 The Mental State Examination & Suicide Risk Stratification

Mental state examination and psychotic symptoms Suicide formulation and mental health law

35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers

Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT

36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder

Anxiety, panic and agoraphobia OCD and trauma-related disorders

37 Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychosis assessment and antipsychotics Clozapine and severe adverse effects

38 Substance Use Disorders & Acute Withdrawal Syndromes

Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants

39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry

Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry

40 Medicare, PBS, AHPRA & Good Medical Practice Framework

Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications

41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment

Consent, material risks and young people Capacity, refusal and substitute decisions

42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications

Privacy, disclosure and child reporting Driving fitness and threat disclosure

43 First Nations health and preventive care

First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention

44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases

Epidemiology, calculations, bias and surveillance

45 Neurological presentations

Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness

46 Musculoskeletal pain

Back, neck, bone and soft tissue pain

47 Eye presentations

Altered vision and retinal disease Red eye, ocular injury and discharge

48 Ear, nose, throat and oral health

Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis

49 Skin, hair and nails

Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities

50 Breast health and feeding

Breast lumps, discharge and breastfeeding problems

51 Sexual and reproductive presentations

Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction

52 Palliative care and carers

The dying patient, symptoms and carers

53 Eating disorders and personality care

Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care

54 Sleep presentations

Insomnia, snoring and daytime sleepiness

55 Poisoning, resuscitation and environmental emergencies

Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning

56 Communication, rights and professional practice

Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health

57 Genetics, research and donation

Genetic testing, research and organ donation

58 Travel, fever and outbreaks

Fever, travellers and outbreak response

Pneumonia and infected pleural collections

Key Takeaways Explain This Topic AI

CURB-65 and SMART-COP support assessment but do not replace clinical judgement.

Every aspiration event does not require additional anaerobic antibiotic cover.

Frank pleural pus requires urgent drainage assessment.

Last updated: October 2026

Clinical Evaluation and Pathogen Spectrum

Pneumonia represents acute infection and inflammation of the pulmonary parenchymal tissue. Lower respiratory tract infections contribute substantially to acute hospital admissions and critical care utilisation in Australia. Distinguishing community-acquired pneumonia (CAP) from hospital-acquired pneumonia (HAP) and aspiration syndromes is paramount for directing effective empirical antimicrobial therapy.

Causative Pathogens in Community-Acquired Pneumonia

Typical Bacterial Organisms:

Pneumococcus: An important cause of bacterial CAP, but not the dominant organism in every age group and setting. Viruses, atypical organisms and hospital-acquired pathogens alter the differential and treatment.

Haemophilus influenzae : Frequent in patients with pre-existing structural lung disease, particularly COPD and bronchiectasis.

Moraxella catarrhalis : Commonly colonises elderly individuals and patients with chronic respiratory compromise.

Staphylococcus aureus : Less common in uncomplicated CAP, but frequently causes severe, necrotising, cavitating pneumonia following influenza infection.

Atypical Bacterial Organisms:

Mycoplasma pneumoniae : Frequently affects school-aged children, teenagers, and young adults. Manifests with gradual insidious onset, constitutional symptoms (headache, malaise, low-grade fever), persistent non-productive dry cough, and extrapulmonary manifestations including autoimmune cold-agglutinin haemolytic anaemia, erythema multiforme, and bullous myringitis.

Legionella pneumophila and Legionella longbeachae : In Australia, L. longbeachae is uniquely common and linked to gardening compost and commercial potting mix inhalation, whereas L. pneumophila is contracted from contaminated aerosolised water sources (cooling towers, air conditioning systems). Clinical hallmarks include high spiking fevers, profound confusion or encephalopathy out of proportion to fever, prominent gastrointestinal symptoms (watery diarrhoea, nausea, vomiting), and laboratory abnormalities including marked hyponatraemia, elevated liver transaminases, and microscopic haematuria.

Chlamydia pneumoniae and Chlamydia psittaci : C. psittaci arises from bird exposure (parrots, pigeons, poultry) and causes severe systemic illness with hepatosplenomegaly.

Hospital-Acquired and Aspiration Pneumonia:

Hospital-Acquired Pneumonia (HAP): Pneumonia occurring 48 hours or more following hospital admission that was not incubating at presentation. Pathogen spectrum shifts toward multidrug-resistant hospital flora, including Gram-negative bacilli ( Pseudomonas aeruginosa , Klebsiella pneumoniae , Enterobacter species) and Methicillin-Resistant Staphylococcus aureus (MRSA).

Aspiration syndromes: Distinguish chemical pneumonitis from bacterial pneumonia after aspiration. Routine extra anaerobic cover is not required for every aspiration event; abscess, empyema and the clinical setting influence treatment. Assess swallowing and recurrence risk.

Risk Stratification: SMART-COP vs CURB-65

Accurate risk stratification guides site-of-care decisions (outpatient versus general medical ward versus intensive care unit) and determines the breadth and route of antimicrobial coverage.

The SMART-COP Score

The SMART-COP tool was developed and validated in Australia by the Australian CAP Study Collaboration (Charles et al., 2008). It was designed specifically to predict the need for Intensive Respiratory or Vasopressor Support (IRVS) , addressing the known limitation of older scores (such as CURB-65) that heavily weight advanced age and may underestimate severity in younger patients with acute respiratory failure.

S : Clinical Criterion: Systolic Blood Pressure < 90 mmHg < 90\text{ mmHg} < 90 mmHg ; Points Allocated: 2 points

M : Clinical Criterion: Multilobar chest radiograph involvement; Points Allocated: 1 point

A : Clinical Criterion: Albumin < 35 g/L < 35\text{ g/L} < 35 g/L ; Points Allocated: 1 point

R : Clinical Criterion: Respiratory Rate ≥ 25 breaths/min \ge 25\text{ breaths/min} ≥ 25 breaths/min (age ≤ 50 \le 50 ≤ 50 ) or ≥ 30 breaths/min \ge 30\text{ breaths/min} ≥ 30 breaths/min (age > 50 > 50 > 50 ); Points Allocated: 1 point

T : Clinical Criterion: Tachycardia with Heart Rate ≥ 125 bpm \ge 125\text{ bpm} ≥ 125 bpm ; Points Allocated: 1 point

C : Clinical Criterion: Confusion (acute onset of altered mental state); Points Allocated: 1 point

O : Clinical Criterion: Oxygenation Deficit PaO 2 < 70 mmHg \text{PaO}_2 < 70\text{ mmHg} PaO 2 ​ < 70 mmHg or SpO 2 ≤ 93 % \text{SpO}_2 \le 93\% SpO 2 ​ ≤ 93% (age ≤ 50 \le 50 ≤ 50 ); PaO 2 < 60 mmHg \text{PaO}_2 < 60\text{ mmHg} PaO 2 ​ < 60 mmHg or SpO 2 ≤ 90 % \text{SpO}_2 \le 90\% SpO 2 ​ ≤ 90% (age > 50 > 50 > 50 ); Points Allocated: 2 points

P : Clinical Criterion: Arterial pH < 7.35 < 7.35 < 7.35 ; Points Allocated: 2 points

SMART-COP 0 to 2 points: Low risk of needing IRVS (typically suitable for outpatient or short-stay management).

SMART-COP 3 to 4 points: Moderate risk of needing IRVS (general hospital ward admission indicated).

SMART-COP 5 to 6 points: High risk of needing IRVS (approximately 1 in 3 require ICU/HDU admission).

SMART-COP ≥ 7 \ge 7 ≥ 7 points: Very high risk of needing IRVS (approximately 2 in 3 require ICU/HDU admission).

CURB-65 Framework

CURB-65 predicts 30-day all-cause mortality:

  • C: Confusion (abbreviated mental test score ≤ 8 \le 8 ≤ 8 or new disorientation)
  • U: Urea > 7 mmol/L > 7\text{ mmol/L} > 7 mmol/L
  • R: Respiratory rate ≥ 30 breaths/min \ge 30\text{ breaths/min} ≥ 30 breaths/min

B: Blood pressure (Systolic < 90 mmHg < 90\text{ mmHg} < 90 mmHg or Diastolic ≤ 60 mmHg \le 60\text{ mmHg} ≤ 60 mmHg )

65: Age ≥ 65 years \ge 65\text{ years} ≥ 65 years

A score of 0 to 1 indicates low mortality risk (outpatient management), a score of 2 indicates intermediate risk (short inpatient admission), and a score ≥ 3 \ge 3 ≥ 3 indicates high mortality risk (inpatient admission with urgent ICU assessment).

Selecting antimicrobial treatment

Assess illness severity, prior antibiotics, allergies, kidney function, exposures and local resistance. Obtain cultures when indicated without delaying treatment of severe disease. Use the current Australian Therapeutic Guidelines or hospital protocol for the regimen and dose, then narrow treatment as microbiology and clinical response become clear. Hospital-acquired infection and immunocompromise need different pathways from uncomplicated community-acquired pneumonia. Review the diagnosis if the patient fails to improve; obstruction, pulmonary embolism, malignancy and a pleural collection can mimic or complicate infection.

Pleural Space Infections: Parapneumonic Effusion and Empyema

Pneumonic consolidation frequently irritates the adjacent visceral pleura, producing a parapneumonic effusion. Effusions evolve through three continuous stages: exudative (simple parapneumonic), fibropurulent (complicated parapneumonic), and organised (chronic empyema with pleural peel).

Diagnostic Thoracentesis

Any pleural effusion associated with pneumonia that measures > 10 mm > 10\text{ mm} > 10 mm on a lateral decubitus radiograph or is clearly visible on thoracic ultrasound warrants prompt diagnostic thoracentesis to differentiate simple from complicated effusions.

Macroscopic Appearance : Simple Parapneumonic: Clear, straw-coloured; Complicated Parapneumonic: Cloudy, turbid; Empyema: Frank pus, viscous, foul-smelling

Pleural Fluid pH : Simple Parapneumonic: ≥ 7.20 \ge 7.20 ≥ 7.20 ; Complicated Parapneumonic: < 7.20 < 7.20 < 7.20 ; Empyema: < 7.20 < 7.20 < 7.20

Pleural Fluid Glucose : Simple Parapneumonic: ≥ 3.3 mmol/L \ge 3.3\text{ mmol/L} ≥ 3.3 mmol/L ; Complicated Parapneumonic: < 3.3 mmol/L < 3.3\text{ mmol/L} < 3.3 mmol/L ; Empyema: Markedly reduced ( < 2.2 mmol/L < 2.2\text{ mmol/L} < 2.2 mmol/L )

Pleural Fluid LDH : Simple Parapneumonic: < 1000 IU/L < 1000\text{ IU/L} < 1000 IU/L ; Complicated Parapneumonic: > 1000 IU/L > 1000\text{ IU/L} > 1000 IU/L ; Empyema: Typically > 1000 IU/L > 1000\text{ IU/L} > 1000 IU/L

Microbiology : Simple Parapneumonic: Negative Gram stain and culture; Complicated Parapneumonic: Often negative (sterile inflammation); Empyema: Positive Gram stain or bacterial culture

Primary Management : Simple Parapneumonic: Systemic antibiotics alone; Complicated Parapneumonic: Chest tube thoracostomy drainage + IV antibiotics; Empyema: Chest tube thoracostomy drainage + IV antibiotics +/- fibrinolytics/VATS

Management of Complicated Parapneumonic Effusion and Empyema

Pleural infection: Frank pus or positive pleural microbiology requires drainage assessment. A reliable pH at or below 7.2 supports drainage when a safe fluid target exists; glucose, LDH, imaging and clinical course matter in intermediate cases. Involve respiratory specialists and do not apply one isolated number without checking sampling quality.

Intravenous Antimicrobials: Broad-spectrum coverage targeting community or hospital pathogens plus oral anaerobes: IV ceftriaxone ( 2 g 2\text{ g} 2 g daily) PLUS IV metronidazole ( 500 mg 500\text{ mg} 500 mg 8-hourly).

Intrapleural Fibrinolytics and Surgery: In multiloculated empyemas with persistent non-draining collections, intrapleural tissue plasminogen activator (tPA, alteplase 10 mg 10\text{ mg} 10 mg ) combined with deoxyribonuclease (DNase 5 mg 5\text{ mg} 5 mg ) twice daily for 3 days facilitates drainage. If medical and intrapleural therapy fails, video-assisted thoracoscopic surgery (VATS) decortication is required.

Primary references (checked 7 October 2026): NSW adult pneumonia pathway .